{"id":"NCT02984384","sponsor":"Major Extremity Trauma Research Consortium","briefTitle":"PREVENTion of Clot in Orthopaedic Trauma","officialTitle":"PREVENTion of Clot in Orthopaedic Trauma (PREVENT CLOT): A Randomized Pragmatic Trial Comparing the Complications and Safety of Blood Clot Prevention Medicines Used in Orthopaedic Trauma Patients","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-04-24","primaryCompletion":"2022-02-18","completion":"2022-02-18","firstPosted":"2016-12-06","resultsPosted":"2024-05-14","lastUpdate":"2024-05-14"},"enrollment":12424,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"SINGLE","primaryPurpose":"PREVENTION"},"conditions":["Blood Clot","Trauma"],"interventions":[{"type":"DRUG","name":"Acetylsalicylic acid","otherNames":["Aspirin"]},{"type":"DRUG","name":"Low Molecular Weight Heparin (LMWH)","otherNames":["Enoxaparin"]}],"arms":[{"label":"Low Molecular Weight Heparin (LMWH)-Enoxaparin","type":"ACTIVE_COMPARATOR"},{"label":"Acetylsalicylic acid (ASA)-Aspirin","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to compare aspirin versus low-molecular weight heparin (LMWH) (Enoxaparin) as a thromboprophylaxis in patients who sustain a fracture.","primaryOutcome":{"measure":"Number of Participants With All-cause Mortality","timeFrame":"90 days","effectByArm":[{"arm":"Low Molecular Weight Heparin (LMWH)-Enoxaparin","deltaMin":45,"sd":null},{"arm":"Acetylsalicylic Acid (ASA)-Aspirin","deltaMin":47,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":17},"locations":{"siteCount":21,"countries":["United States","Canada"]},"refs":{"pmids":["33762229","36652352","31604788"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":260,"n":6110},"commonTop":["Bleeding complication","Wound complication"]}}